spironolactone has been researched along with tiletamine hydrochloride in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miyanaga, W; Ohkata, K; Takagi, R; Tamura, Y | 1 |
Brückner, R; Petrović, D | 1 |
Bachari, K; Bouhenna, MM; Diederich, M; Mameri, N; Orlikova, B; Pinto, DCGA; Schram, B; Silva, AMS; Taibi, N; Talhi, O | 1 |
3 other study(ies) available for spironolactone and tiletamine hydrochloride
Article | Year |
---|---|
Efficient synthesis of a 4,5-epoxy-2-cyclohexen-1-one derivative bearing a spirolactone via a Diels-Alder reaction with high pi-facial selectivity: a synthetic study towards scyphostatin.
Topics: Amides; Cyclohexanones; Pyrones; Spironolactone | 2002 |
Deslongchamps annulations with benzoquinone monoketals.
Topics: Benzoquinones; Catalysis; Cyclohexanones; Ketones; Molecular Structure; Spiro Compounds; Spironolactone; Stereoisomerism | 2011 |
Anti-proliferative, Cytotoxic and NF-ĸB Inhibitory Properties of Spiro(Lactone-Cyclohexanone) Compounds in Human Leukemia.
Topics: Biological Assay; Caspase 3; Caspase 7; Cell Death; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Cyclohexanones; Humans; K562 Cells; Leukemia; NF-kappa B; Spironolactone; Stereoisomerism; Tumor Necrosis Factor-alpha; U937 Cells | 2017 |